Evidence map›Paper›PMID 40397381›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Accurate Transcription Factor Activity Inference to Decipher Cell Identity from Single-Cell Transcriptomic Data with MetaTF.

Yongfei Hu, Yuanyuan Zhu, Guangjue Tang, Ming Shan, Puwen Tan, Ying Yi, Xiyuan Zhang, Man Liu, Xinyu Li, Le Wu and 6 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Yongfei HuDepartment of Bioinformatics, Guangdong Province Key Laboratory of Molecular Tumor Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
Yuanyuan ZhuDepartment of Pathology, School of Basic Medical Sciences, Harbin Medical University, Harbin, 150081, China.
Guangjue TangDepartment of Bioinformatics, Guangdong Province Key Laboratory of Molecular Tumor Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
Ming ShanDepartment of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, 150000, China.
Puwen TanDepartment of Bioinformatics, Guangdong Province Key Laboratory of Molecular Tumor Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
Ying YiDermatology Hospital, Southern Medical University, Guangzhou, 510091, China.
Xiyuan ZhangDepartment of Pathology, School of Basic Medical Sciences, Harbin Medical University, Harbin, 150081, China.
Man LiuDepartment of Pathology, School of Basic Medical Sciences, Harbin Medical University, Harbin, 150081, China.
Xinyu LiDepartment of Bioinformatics, Guangdong Province Key Laboratory of Molecular Tumor Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
Le WuDepartment of Bioinformatics, Guangdong Province Key Laboratory of Molecular Tumor Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
Jia ChenDepartment of Bioinformatics, Guangdong Province Key Laboratory of Molecular Tumor Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
Hailong ZhengDepartment of Bioinformatics, Guangdong Province Key Laboratory of Molecular Tumor Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
Yan HuangCancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
Zhuan LiKey Laboratory of Functional Proteomics of Guangdong Province, Department of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510060, China.
Xiaobo LiDepartment of Pathology, School of Basic Medical Sciences, Harbin Medical University, Harbin, 150081, China.
Dong WangDepartment of Bioinformatics, Guangdong Province Key Laboratory of Molecular Tumor Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.ORCID https://orcid.org/0000-0002-6860-6864

Funding

Chinese Foundation for Primary Health Care cphcf-2023-018Guangdong Basic and Applied Basic Research Foundation 2024A1515011769Haiyan Foundation of Harbin Medical University Cancer Hospital JJZD2024-02Joint Funds of the National Natural Science Foundation of China U24A20724National Key Research and Development Project of China 2022YFA0806303National Natural Science Foundation of China 82273364National Natural Science Foundation of China 82370106National Natural Science Foundation of China Excellent Young Fund 32422026
6 · The paper itself

Abstract

Cellular heterogeneity within cancer tissues determines cancer progression and treatment response. Single-cell RNA sequencing (scRNA-seq) has provided a powerful approach for investigating the cellular heterogeneity of both cancer cells and stroma cells in the tumor microenvironment. However, the common practice to characterize cell identity based on the similarity of their gene expression profiles may not really indicate distinct cellular populations with unique roles. Generally, the cell identity and function are orchestrated by the expression of given specific genes tightly regulated by transcription factors (TFs). Therefore, deciphering TF activity is essential for gaining a better understanding of the uniqueness and functionality of each cell type. Herein, metaTF, a computational framework designed to infer TF activity in scRNA-seq data, is introduced and existing methods are outperformed for estimating TF activity. It presents the improved effectiveness in characterizing cell identity during mouse hematopoietic stem cell development. Furthermore, metaTF provides a superior characterization of the functional identity of breast cancer epithelial cells, and identifies a novel subset of neural-regulated T cells within the tumor immune microenvironment, which potentially activates BCL6 in response to neural-related signals. Overall, metaTF enables robust TF activity analysis from scRNA-seq data, significantly enhancing the characterization of cell identity and function.

Indexed as

Computational BiologySingle-Cell AnalysisTranscription FactorsTranscriptomeAnimalsFemaleGene Expression ProfilingHumansMiceSequence Analysis, RNATumor MicroenvironmentTranscription Factorscell identityscRNA‐seqtranscription factor activitytumor immune microenvironment

Identifiers

PMID40397381
PMCPMC12199337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.